Disruptive innovations happen when different technology domains join forces.
In 2022 MEDVIA supported by VLAIO provides €8 million earmarked non-dilutive funding for innovations in biotechnology, medical technology, and digital technology.
The projects – combining at least two of the above domains – should develop disruptive solutions for a clearly defined unmet need in healthcare or pool their research strengths to gain knowledge that will lead to such solutions. The results need to lead to a quantifiable increase in investment and employment in Flanders.
Your project should connect with one of our four overarching themes: Value-based healthcare, personalised medicine, digital medicine, or disruptive health solutions.
Full detail of the criteria and deadlines can be found in the PDF document.
We opened four different VLAIO grant schemes:
We help you succeed.
MEDVIA assists participants with the preparation of their proposal. Of course, all participants bear full and final responsibility for writing and preparing a proposal that meets the criteria set by VLAIO for the respective grant schemes.
In 2021 a pilot call for projects was launched. Many companies, hospitals and care organization participated, resulting in 75 valuable ideas for collaborative projects matching the strategy of MEDVIA. Our independent international jury validated the project ideas and selected the most mature projects for submission of a full proposal.
In December 2021, 14 projects received a total of €4,7 million
Flemish Remote And transMural Enhanced recovery program
Johnson & Johnson
Easy data transfer to add relevant output for heart therapies
Long-read sequencing multi-omic platform towards precise rare disease and cancer diagnosis enables personalized clinical procedures.
Electronic diagnostic device to quickly detect globally transmitted infections
AMS Sensors Belgium
3D Printed Bioresorbable Device for Partial Breast Reconstruction
Prostate Cancer Support Tool
Computer-Aided Management of Lower Gastro-Intestinal Neoplasia
Wit-Gele Kruis van Oost-Vlaanderen
2D dosimetry for UHDR electron “FLASH” beams: passive optically stimulated luminescence and real-time scintillating solutions
Interested in our future calls?